StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics total assets

Total assets on the balance sheet at the end of each period.

TFA Therapeutics's total assets was $4.66M at Dec 31, 2025. For fiscal 2025 it was $4.66M, up 0.7% from the year before. The highest annual figure on record is $4.66M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.66M+0.7%
FY2024Dec 31, 2024$4.62M+37.9%
FY2023Dec 31, 2023$3.35M+59.2%
FY2022Dec 31, 2022$2.10M-35.5%
FY2021Dec 31, 2021$3.26M+15.5%
FY2020Dec 31, 2020$2.83M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$4.66M+121.3%
Q4 FY2024Dec 31, 2024$4.62M+41.7%
Q4 FY2023Dec 31, 2023$3.35M+18.6%
Q3 FY2023Sep 30, 2023$1.80M–
Q4 FY2022Dec 31, 2022$2.10M–
Q4 FY2021Dec 31, 2021$3.26M–
Q4 FY2020Dec 31, 2020$2.83M–

More TFA Therapeutics figures

See a number that looks wrong?